Luteal phase ovarian stimulation with Follitropin delta and dydrogesterone: a randomized cross over pilot trial

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-513998-48-00

Acronym

CS-10459

Enrollment

Registered

2024-07-31

Start date

2023-02-02

Completion date

Unknown

Last updated

2024-07-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Volutary women who wish to donate their oocytes

Brief summary

Total number of retrieved COCs

Detailed description

Endocrine profile in both treatment groups, Consumption (mcg) of gonadotrophins, Duration of ovarian stimulation, Days of progestin use, Total number of MII oocytes

Interventions

DRUGREKOVELLE 36 micrograms/1.08 mL solution for injection in a pre-filled pen

DRUGREKOVELLE 12 micrograms/0.36 mL solution for injection in a pre-filled pen

DRUGDuphaston 10 mg filmomhulde tabletten

DRUGREKOVELLE 72 micrograms/2.16 mL solution for injection in a pre-filled pen

DRUGDuphaston 10 mg comprimés pelliculés

DRUGDuphaston 10 mg Filmtabletten

Eligibility

Sex/Gender

All

Age

18 Years to 64 Years

Design outcomes

Primary

Measure	Time frame
Total number of retrieved COCs	—

Secondary

Measure	Time frame
Endocrine profile in both treatment groups, Consumption (mcg) of gonadotrophins, Duration of ovarian stimulation, Days of progestin use, Total number of MII oocytes	—

Countries

Belgium

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026